TY - JOUR
T1 - The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients
AU - Liu, Julia J.
AU - Abraham, Bincy P.
AU - Adamson, Paula
AU - Barnes, Edward L.
AU - Brister, Kelly A.
AU - Damas, Oriana M.
AU - Glover, Sarah C.
AU - Hooks, Kimberly
AU - Ingram, Ana
AU - Kaplan, Gilaad G.
AU - Loftus, Edward V.
AU - McGovern, Dermot P.B.
AU - Narain-Blackwell, Melodie
AU - Odufalu, Florence Damilola
AU - Quezada, Sandra
AU - Reeves, Vonda
AU - Shen, Bo
AU - Stappenbeck, Thaddeus S.
AU - Ward, Latonia
N1 - Publisher Copyright:
© The Author(s) 2022. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
PY - 2023/2/1
Y1 - 2023/2/1
N2 - Research on the care of inflammatory bowel disease (IBD) patients has been primarily in populations of European ancestry. However, the incidence of IBD, which comprises Crohn's disease and ulcerative colitis, is increasing in different populations around the world. In this comprehensive review, we examine the epidemiology, clinical presentations, disease phenotypes, treatment outcomes, social determinants of health, and genetic and environmental factors in the pathogenesis of IBD in Black and Hispanic patients in the United States. To improve health equity of underserved minorities with IBD, we identified the following priority areas: access to care, accurate assessment of treatment outcomes, incorporation of Black and Hispanic patients in therapeutic clinical trials, and investigation of environmental factors that lead to the increase in disease incidence.
AB - Research on the care of inflammatory bowel disease (IBD) patients has been primarily in populations of European ancestry. However, the incidence of IBD, which comprises Crohn's disease and ulcerative colitis, is increasing in different populations around the world. In this comprehensive review, we examine the epidemiology, clinical presentations, disease phenotypes, treatment outcomes, social determinants of health, and genetic and environmental factors in the pathogenesis of IBD in Black and Hispanic patients in the United States. To improve health equity of underserved minorities with IBD, we identified the following priority areas: access to care, accurate assessment of treatment outcomes, incorporation of Black and Hispanic patients in therapeutic clinical trials, and investigation of environmental factors that lead to the increase in disease incidence.
KW - disparity
KW - outcomes
KW - pathogenesis
UR - http://www.scopus.com/inward/record.url?scp=85142189817&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142189817&partnerID=8YFLogxK
U2 - 10.1093/ibd/izac124
DO - 10.1093/ibd/izac124
M3 - Review article
C2 - 35816130
AN - SCOPUS:85142189817
VL - 29
SP - 297
EP - 307
JO - Inflammatory bowel diseases
JF - Inflammatory bowel diseases
SN - 1078-0998
IS - 2
ER -